Viewing nowGlymepiride Tablets 2mg (Glymepiride)
Glimepiride 2mg
Tablet · Prescription medication
Boryung Biopharma Co., Ltd.

MFDS item code 201902153 · Approved 2019.04.09 · Insurance code 670501550
Improvement of blood sugar control in type 2 diabetes
This medication is used to improve blood sugar control in patients with type 2 diabetes. It is administered as an adjunct when patients cannot control their blood sugar with diet and exercise alone and can be used as a monotherapy. If control is insufficient with oral hypoglycemics, it can be combined with insulin, and if not controlled with sulfonylureas or metformin monotherapy, it can be combined with metformin to enhance efficacy. This medication effectively helps improve blood sugar control in diabetic patients.
Adjusted individually for each patient. This medication is taken orally once daily, before breakfast or just before the first meal. The initial dose is 1 mg once daily, increasing by 1 mg at intervals of 1–2 weeks as needed. Generally, doses above 4 mg provide little additional effect, but some patients may increase to 6 mg or 8 mg. If 4 mg daily fails, consider a switch to insulin therapy before considering the combination with insulin or other oral hypoglycemics.
This medication is not to be used in patients with insulin-dependent diabetes or in patients with diabetic ketoacidosis or in a comatose state. Additionally, those who have had an allergic reaction to this medication or sulfonylureas should not take it. There is no experience with this medication in patients with severely impaired liver or kidney function, and in such cases transitioning to insulin therapy is recommended. Women who are pregnant or may become pregnant, as well as nursing mothers, should not take this medication. In patients with severe infections or those undergoing surgery or with severe trauma, insulin therapy is more appropriate. Patients with gastrointestinal disorders like diarrhea or vomiting should be cautious as food absorption may be inadequate, increasing the risk of hypoglycemia. This medication contains lactose, and individuals with certain genetic metabolic disorders should not take it. During the first week of dosing, the risk of hypoglycemia is increased, so blood sugar levels must be carefully monitored, especially in elderly patients, those with poor nutritional status or irregular eating habits, and those with impaired kidney or liver function. Those who frequently consume alcohol or take other medications simultaneously may also have an increased risk of hypoglycemia, so consult a physician. This medication contains Yellow No. 4 dye, and those allergic to this ingredient should use it cautiously. Symptoms of hypoglycemia may include headache, severe hunger, nausea, fatigue, drowsiness, confusion, and in severe cases, loss of consciousness; if these symptoms occur, quickly consume sugar or inform a healthcare professional. Temporary blurred vision can occur, and gastrointestinal disorders, liver function abnormalities, and changes in blood cell counts have also been reported. Allergic reactions may include skin rashes, itching, and in severe cases, breathing difficulties or shock, so if symptoms appear, discontinue use immediately and consult a hospital. This medication must be combined with dietary therapy and exercise for blood sugar control, and regular intake is important. If hypoglycemia occurs, sugar should be quickly consumed, and artificial sweeteners will not be effective, so caution is needed. When receiving treatment at another hospital or pharmacy, be sure to inform them of this medication, and during stressful situations or surgeries, blood sugar management methods may change, so consult a physician. In the case of an overdose, hypoglycemia may lead to a comatose state, requiring immediate emergency treatment, and after use, proper storage away from children's reach is essential.
Hives, severe swelling (edema), difficulty breathing, jaundice (yellowing of the skin or eyes), extreme lethargy, thrombocytopenia, leukopenia, hemolytic anemia, erythrocytopenia, agranulocytosis, pancytopenia, anaphylaxis, angioedema, skin and mucous membrane syndrome (Stevens-Johnson syndrome), shock, liver dysfunction (bile secretion disorders, jaundice), hepatitis, cerebral convulsions, confusion of consciousness, severe hypoglycemia
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a sealed container to protect it from air or moisture, and it is safest to store at room temperature between 1°C and 30°C.
Green rectangular tablets
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowGlimepiride 2mg
Tablet · Prescription medication
Boryung Biopharma Co., Ltd.

Glimepiride 1mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 4mg
Tablet · Prescription medication
(Hanmi Pharmaceutical Co., Ltd.)

Glimepiride 2mg
Tablet · Prescription medication
Seoul Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
IYun Pharmaceuticals Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.